Newly detected atrial fibrillation and compliance with antithrombotic guidelines.

@article{Glazer2007NewlyDA,
  title={Newly detected atrial fibrillation and compliance with antithrombotic guidelines.},
  author={Nicole L. Glazer and Sascha Dublin and Nicholas L. Smith and Benjamin French and Lisa A. Jackson and Jennifer B Hrachovec and David S Siscovick and Bruce M. Psaty and Susan R. Heckbert},
  journal={Archives of internal medicine},
  year={2007},
  volume={167 3},
  pages={246-52}
}
BACKGROUND Guidelines recommend the use of antithrombotic therapy for stroke prevention in patients with atrial fibrillation (AF), but compliance with such guidelines has not been widely studied among patients with newly detected AF. Our objective was to assess compliance with antithrombotic guidelines and to identify patient characteristics associated with warfarin use. METHODS A population-based study of newly detected AF (patient age, 30-84 years) was conducted within a large health plan… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 64 extracted citations

New anticoagulants for atrial fibrillation.

Seminars in thrombosis and hemostasis • 2009
View 6 Excerpts
Highly Influenced

New oral anticoagulants in atrial fibrillation.

European heart journal • 2008
View 18 Excerpts
Highly Influenced

Aspirin in Atrial Fibrillation: The Clot Thickens.

Journal of the American College of Cardiology • 2016

Similar Papers

Loading similar papers…